{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T08:04:17Z","timestamp":1767773057254},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2012,10,29]],"date-time":"2012-10-29T00:00:00Z","timestamp":1351468800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1038\/aps.2012.111","type":"journal-article","created":{"date-parts":[[2012,10,29]],"date-time":"2012-10-29T13:19:09Z","timestamp":1351516749000},"page":"1549-1556","source":"Crossref","is-referenced-by-count":11,"title":["A single-dose toxicity study on non-radioactive iodinated hypericin for a targeted anticancer therapy in mice"],"prefix":"10.1038","volume":"33","author":[{"given":"Jun-jie","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlein Miranda","family":"Cona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-bo","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-zhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-bin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Himmelreich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Oyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfons","family":"Verbruggen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-cheng","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,29]]},"reference":[{"key":"BFaps2012111_CR1","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1055\/s-2007-969321","volume":"(6)","author":"J H\u00f6lzl","year":"1986","unstructured":"H\u00f6lzl J, Ostrowski E . Analysis of the Essential Compounds of Hypericum perforatum. Planta Med 1986; (6): 531.","journal-title":"Planta Med"},{"key":"BFaps2012111_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0378-8741(86)90087-5","volume":"16","author":"F Tammaro","year":"1986","unstructured":"Tammaro F, Xepapadakis G . Plants used in phytotherapy, cosmetics and dyeing in the Pramanda district (Epirus, North-West Greece). J Ethnopharmacol 1986; 16: 167\u201374.","journal-title":"J Ethnopharmacol"},{"key":"BFaps2012111_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00035-007-0777-z","volume":"117","author":"C Crak","year":"2007","unstructured":"Crak C, Radusiene J, Janulis V, Ivanauskas L . Secondary metabolites in Hypericum perfoliatum: variation among plant parts and phenological stages. Bot Helv 2007; 117: 29\u201336.","journal-title":"Bot Helv"},{"key":"BFaps2012111_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0168-9452(99)00178-8","volume":"150","author":"ACP Diasa","year":"2000","unstructured":"Diasa ACP, Seabrab RM, Andradeb PB, Ferreresc F, Fernandes-Ferreiraa M . Xanthone biosynthesis and accumulation in calli and suspended cells of Hypericum androsaemum. Plant Sci 2000; 150: 93\u2013101.","journal-title":"Plant Sci"},{"key":"BFaps2012111_CR5","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3390\/ijms11020562","volume":"11","author":"A Karioti","year":"2010","unstructured":"Karioti A, Bilia AR . Hypericins as potential leads for new therapeutics. Int J Mol Sci 2010; 11: 562\u201394.","journal-title":"Int J Mol Sci"},{"key":"BFaps2012111_CR6","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1007\/s00432-011-1032-y","volume":"137","author":"T Marysael","year":"2011","unstructured":"Marysael T, Ni Y, Lerut E, de Witte P . Influence of the vascular damaging agents DMXAA and ZD6126 on hypericin distribution and accumulation in RIF-1 tumors. J Cancer Res Clin Oncol 2011; 137: 1619\u201327.","journal-title":"J Cancer Res Clin Oncol"},{"key":"BFaps2012111_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2174\/1381612053382287","volume":"11","author":"A Kubin","year":"2005","unstructured":"Kubin A, Wierrani F, Burner U, Alth G, Gr\u00fcnberger W . Hypericin \u2014 the facts about a controversial agent. Curr Pharm Des 2005; 11: 233\u201353.","journal-title":"Curr Pharm Des"},{"key":"BFaps2012111_CR8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S1357-2725(01)00126-1","volume":"34","author":"P Agostinis","year":"2002","unstructured":"Agostinis P, Vantieghem A, Merlevede W, de Witte PA . Hypericin in cancer treatment: more light on the way. Int J Biochem Cell Biol 2002; 34: 221\u201341.","journal-title":"Int J Biochem Cell Biol"},{"key":"BFaps2012111_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1477-7819-4-87","volume":"4","author":"CS Head","year":"2006","unstructured":"Head CS, Luu Q, Sercarz J, Saxton R . Photodynamic therapy and tumor imaging of hypericin-treated squamous cell carcinoma. World J Surg Oncol 2006; 4: 87.","journal-title":"World J Surg Oncol"},{"key":"BFaps2012111_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2174\/1381612053382287","volume":"11","author":"A Kubin","year":"2005","unstructured":"Kubin A, Wierrani F, Burner U, Alth G, Gr\u00fcnberger W . Hypericin \u2014 the facts about a controversial agent. Curr Pharm Des 2005; 11: 233\u201353.","journal-title":"Curr Pharm Des"},{"key":"BFaps2012111_CR11","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00259-005-0013-2","volume":"33","author":"Y Ni","year":"2006","unstructured":"Ni Y, Huyghe D, Verbeke K, de Witte PA, Nuyts J, Mortelmans L, et al. First preclinical evaluation of mono-[123I]iodohypericin as a necrosis-avid tracer agent. Eur J Nucl Med Mol Imaging 2006; 33: 595\u2013601.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"BFaps2012111_CR12","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/01.rli.0000171811.48991.5a","volume":"40","author":"Y Ni","year":"2005","unstructured":"Ni Y, Bormans G, Chen F, Verbruggen A, Marchal G . Necrosis avid contrast agents: functional similarity versus structural diversity. Invest Radiol 2005; 40: 526\u201335.","journal-title":"Invest Radiol"},{"key":"BFaps2012111_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11523-012-0212-2","volume":"7","author":"J Li","year":"2012","unstructured":"Li J, Chen F, Cona MM, Feng Y, Himmelreich U, Oyen R, et al. A review on various targeted anticancer therapies. Target Oncol 2012; 7: 69\u201385.","journal-title":"Target Oncol"},{"key":"BFaps2012111_CR14","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/eurheartj\/ehm588","volume":"29","author":"H Fonge","year":"2008","unstructured":"Fonge H, Vunckx K, Wang H, Feng Y, Mortelmans L, Nuyts J, et al. Non-invasive detection and quantification of acute myocardial infarction in rabbits using mono-[123I]iodohypericin microSPECT. Eur Heart J 2008; 29: 260\u20139.","journal-title":"Eur Heart J"},{"key":"BFaps2012111_CR15","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1148\/radiol.11102120","volume":"260","author":"J Li","year":"2011","unstructured":"Li J, Sun Z, Zhang J, Shao H, Cona MM, Wang H, et al. A dual-targeting anticancer approach: soil and seed principle. Radiology 2011; 260: 799\u2013807.","journal-title":"Radiology"},{"key":"BFaps2012111_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.acra.2007.08.008","volume":"15","author":"M Van de Putte","year":"2008","unstructured":"Van de Putte M, Wang H, Chen F, de Witte PA, Ni Y . Hypericin as a marker for determination of tissue viability after intratumoral ethanol injection in a murine liver tumor model. Acad Radiol 2008; 15: 107\u201313.","journal-title":"Acad Radiol"},{"key":"BFaps2012111_CR17","first-page":"927","volume":"19","author":"M Van de Putte","year":"2008","unstructured":"Van de Putte M, Wang H, Chen F, De Witte PA, Ni Y . Hypericin as a marker for determination of tissue viability after radiofrequency ablation in a murine liver tumor model. Oncol Rep 2008; 19: 927\u201332.","journal-title":"Oncol Rep"},{"issue":"6","key":"BFaps2012111_CR18","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1007\/s10637-011-9778-2","volume":"30","author":"Thierry Marysael","year":"2011","unstructured":"Marysael T, Bauwens M, Ni Y, Bormans G, Rozenski J, de Witte P . Pretargeting of necrotic tumors with biotinylated hypericin using 123I-labeled avidin: evaluation of a two-step strategy. Invest New Drugs 2011. doi: 10.1007\/s10637-011-9778-2.","journal-title":"Investigational New Drugs"},{"key":"BFaps2012111_CR19","first-page":"921","volume":"19","author":"M Van de Putte","year":"2008","unstructured":"Van de Putte M, Ni Y, De Witte PA . Exploration of the mechanism underlying the tumor necrosis avidity of hypericin. Oncol Rep 2008; 19: 921\u20136.","journal-title":"Oncol Rep"},{"key":"BFaps2012111_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s002800000188","volume":"47","author":"E Fox","year":"2001","unstructured":"Fox E, Murphy RF, McCully CL, Adamson PC . Plasma pharmacokinetics and cerebrospinal fluid penetration of hypericin in nonhuman primates. Cancer Chemother Pharmacol 2001; 47: 41\u20134.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BFaps2012111_CR21","unstructured":"Leuschner J . Gutachten zur experimentellen Toxikologie von Hypericum-Extract LI 160. Berlin: Lichtwer Pharma GmbH. 1995."},{"key":"BFaps2012111_CR22","doi-asserted-by":"publisher","first-page":"510","DOI":"10.7326\/0003-4819-130-6-199903160-00015","volume":"130","author":"RM Gulick","year":"1999","unstructured":"Gulick RM, McAuliffe V, Holden-Wiltse J, Crumpacker C, Liebes L, Stein DS, et al. Phase I studies of hypericin, the active compound in St. John's wort, as an antiretroviral agent in HIV-infected adults. AIDS Clinical Trials Group Protocols 150 and 258. Ann Intern Med 1999; 130: 510\u20134.","journal-title":"Ann Intern Med"},{"key":"BFaps2012111_CR23","first-page":"19","volume":"39","author":"Y Cui","year":"2005","unstructured":"Cui Y, Liang J, Luo Y, Wang X, Zhu Y, Shang R, et al. Acute toxicity tests of extractum hypericin. Chin J Vet Drug 2005; 39: 19\u201320.","journal-title":"Chin J Vet Drug"},{"key":"BFaps2012111_CR24","first-page":"67","volume":"16","author":"RE Stowell","year":"1941","unstructured":"Stowell RE . Effect on tissue volume of various methods of fixation, dehydration, and embedding. Biotechnic & Histochemistry 1941; 16: 67\u201383.","journal-title":"Biotechnic & Histochemistry"},{"key":"BFaps2012111_CR25","first-page":"436","volume":"39","author":"N Watanabe","year":"1998","unstructured":"Watanabe N, Yokoyama K, Kinuya S, Shuke N, Shimizu M, Futatsuya R, et al. Radiotoxicity after iodine-131 therapy for thyroid cancer using the micronucleus assay. J Nucl Med 1998; 39: 436\u201340.","journal-title":"J Nucl Med"},{"key":"BFaps2012111_CR26","first-page":"2196","volume":"33","author":"VR Narra","year":"1992","unstructured":"Narra VR, Howell RW, Harapanhalli RS, Sastry KS, Rao DV . Radiotoxicity of some iodine-123, iodine-125 and iodine-131-labeled compounds in mouse testes: implications for radiopharmaceutical design. J Nucl Med 1992; 33: 2196\u2013201.","journal-title":"J Nucl Med"},{"key":"BFaps2012111_CR27","first-page":"269","volume":"35","author":"B Shapiro","year":"1991","unstructured":"Shapiro B, Sisson JC, Wieland DM, Mangner TJ, Zempel SM, Mudgett E, et al. Radiopharmaceutical therapy of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: results from ten years of experience. J Nucl Biol Med 1991; 35: 269\u201376.","journal-title":"J Nucl Biol Med"},{"key":"BFaps2012111_CR28","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1200\/JCO.1985.3.12.1573","volume":"3","author":"SE Order","year":"1985","unstructured":"Order SE, Stillwagon GB, Klein JL, Leichner PK, Siegelman SS, Fishman EK, et al. Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study. J Clin Oncol 1985; 3: 1573\u201382.","journal-title":"J Clin Oncol"},{"key":"BFaps2012111_CR29","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1097\/01.LAB.0000090154.55436.D1","volume":"83","author":"V Vincek","year":"2003","unstructured":"Vincek V, Nassiri M, Nadji M, Morales AR . A tissue fixative that protects macromolecules (DNA, RNA, and protein) and histomorphology in clinical samples. Lab Invest 2003; 83: 1427\u201335.","journal-title":"Lab Invest"},{"key":"BFaps2012111_CR30","unstructured":"Finney DJ. Ed. Probit Analysis. Cambridge, England, Cambridge University Press 1952."},{"key":"BFaps2012111_CR31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/biomet\/35.1-2.191","volume":"35","author":"DJ Finney","year":"1948","unstructured":"Finney DJ, Stevens WL . A table for the calculation of working probits and weights in probit analysis. Biometrika 1948; 35: 191\u2013201.","journal-title":"Biometrika"},{"key":"BFaps2012111_CR32","doi-asserted-by":"publisher","first-page":"792","DOI":"10.2967\/jnumed.110.086116","volume":"52","author":"S Song","year":"2011","unstructured":"Song S, Xiong C, Zhou M, Lu W, Huang Q, Ku G, et al. Small-animal PET of tumor damage induced by photothermal ablation with 64Cu-bis-DOTA-hypericin. J Nucl Med 2011; 52: 792\u20139.","journal-title":"J Nucl Med"},{"key":"BFaps2012111_CR33","unstructured":"http:\/\/www.livestrong.com\/article\/107004-hypericin-side-effects\/"},{"key":"BFaps2012111_CR34","first-page":"677","volume":"39","author":"Z Luksiene","year":"2003","unstructured":"Luksiene Z, de Witte PA . Hypericin as novel and promising photodynamic therapy tool: studies on intracellular accumulation capacity and growth inhibition efficiency. Medicina (Kaunas) 2003; 39: 677\u201382.","journal-title":"Medicina (Kaunas)"},{"key":"BFaps2012111_CR35","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/1743-422X-7-375","volume":"7","author":"Y Nagao","year":"2010","unstructured":"Nagao Y, Sata M . Serum albumin and mortality risk in a hyperendemic area of HCV infection in Japan. Virol J 2010; 7: 375.","journal-title":"Virol J"},{"key":"BFaps2012111_CR36","first-page":"449","volume":"57","author":"E Onusko","year":"2008","unstructured":"Onusko E . Statins and elevated liver tests: what's the fuss? J Fam Pract 2008; 57: 449\u201352.","journal-title":"J Fam Pract"},{"key":"BFaps2012111_CR37","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.7150\/thno.4924","volume":"2","author":"J Li","year":"2012","unstructured":"Li J, Cona MM, Chen F, Feng Y, Yu J, De witte P, et al. Exploring theranostic potentials of radioiodinated hypericin in rodent necrosis models. Theranostics 2012; 2: 1010\u20139.","journal-title":"Theranostics"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps2012111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps2012111","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps2012111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:26:59Z","timestamp":1684412819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps2012111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,29]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["BFaps2012111"],"URL":"https:\/\/doi.org\/10.1038\/aps.2012.111","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,29]]}}}